↓ Skip to main content

Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth: Preterm SAMBA

Overview of attention for article published in BMC Pregnancy and Childbirth, August 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
7 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
113 Mendeley
Title
Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth: Preterm SAMBA
Published in
BMC Pregnancy and Childbirth, August 2016
DOI 10.1186/s12884-016-1006-9
Pubmed ID
Authors

Jose G. Cecatti, Renato T. Souza, Karolina Sulek, Maria L. Costa, Louise C. Kenny, Lesley M. McCowan, Rodolfo C. Pacagnella, Silas G. Villas-Boas, Jussara Mayrink, Renato Passini, Kleber G. Franchini, Philip N. Baker, for the Preterm SAMBA and SCOPE study groups

Abstract

Spontaneous preterm birth is a complex syndrome with multiple pathways interactions determining its occurrence, including genetic, immunological, physiologic, biochemical and environmental factors. Despite great worldwide efforts in preterm birth prevention, there are no recent effective therapeutic strategies able to decrease spontaneous preterm birth rates or their consequent neonatal morbidity/mortality. The Preterm SAMBA study will associate metabolomics technologies to identify clinical and metabolite predictors for preterm birth. These innovative and unbiased techniques might be a strategic key to advance spontaneous preterm birth prediction. Preterm SAMBA study consists of a discovery phase to identify biophysical and untargeted metabolomics from blood and hair samples associated with preterm birth, plus a validation phase to evaluate the performance of the predictive modelling. The first phase, a case-control study, will randomly select 100 women who had a spontaneous preterm birth (before 37 weeks) and 100 women who had term birth in the Cork Ireland and Auckland New Zealand cohorts within the SCOPE study, an international consortium aimed to identify potential metabolomic predictors using biophysical data and blood samples collected at 20 weeks of gestation. The validation phase will recruit 1150 Brazilian pregnant women from five participant centres and will collect blood and hair samples at 20 weeks of gestation to evaluate the performance of the algorithm model (sensitivity, specificity, predictive values and likelihood ratios) in predicting spontaneous preterm birth (before 34 weeks, with a secondary analysis of delivery before 37 weeks). The Preterm SAMBA study intends to step forward on preterm birth prediction using metabolomics techniques, and accurate protocols for sample collection among multi-ethnic populations. The use of metabolomics in medical science research is innovative and promises to provide solutions for disorders with multiple complex underlying determinants such as spontaneous preterm birth.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 113 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 111 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 18%
Researcher 17 15%
Student > Master 12 11%
Student > Ph. D. Student 11 10%
Student > Postgraduate 7 6%
Other 15 13%
Unknown 31 27%
Readers by discipline Count As %
Medicine and Dentistry 26 23%
Nursing and Health Professions 12 11%
Biochemistry, Genetics and Molecular Biology 9 8%
Agricultural and Biological Sciences 8 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 17 15%
Unknown 37 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2016.
All research outputs
#14,078,546
of 24,885,505 outputs
Outputs from BMC Pregnancy and Childbirth
#2,482
of 4,641 outputs
Outputs of similar age
#195,996
of 373,070 outputs
Outputs of similar age from BMC Pregnancy and Childbirth
#60
of 102 outputs
Altmetric has tracked 24,885,505 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,641 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 373,070 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.